|Printable version||E-mail this to a friend|
How big data can be used for the development and regulation of medicines
EMA workshop broadcast live on 14-15 November
The European Medicines Agency (EMA) is organising a workshop on 14-15 November 2016 to identify opportunities for big data in medicines development and regulation, and to address the challenges of their exploitation. You can follow a live broadcast of the workshop by clicking on the ‘multimedia’ tab on the event page.
Big data is a term which describes the collection of extremely large sets of information which require specialised computational tools to enable their analysis and exploitation. These vast volumes of data have the capability to significantly contribute to the way the benefit-risk of medicines is assessed over the entire lifecycle. A subset of big data is real world evidence, which encompasses the use of sources such as electronic health records, registries, hospital records and health insurance data. Already used to support pharmacovigilance activities, real world evidence has the potential to support product development and the assessment of performance of a medicine on the market.
While creating huge opportunities, there are also significant challenges in the exploitation of these data. For example there is a need to establish appropriate access to the data, to understand the strengths and limitations of the data and to apply new analytical methods to integrate and analyse heterogeneous datasets in order to generate conclusions which contribute to regulatory decision making. Importantly, compliance with data protection legislation ensuring robust mechanisms to protect patient confidentiality is critical for securing patient trust.
The workshop will bring together a wide range of individuals from the healthcare environment and technology companies, who can inform on the advances being made in the field of big data and the opportunities for its application in medicine regulation. This landscaping exercise will help regulators to determine the best approaches to using big data for the development, authorisation and post-marketing surveillance of medicines.
More details on this workshop’s sessions and speakers are provided in the agenda for the meeting.
Individuals interested in tweeting on this event are invited to use the hashtag #bigdata4medicines.
- Identifying opportunities for ‘big data’ in medicines development and regulatory science (14-15/11/2016)
- Agenda - Identifying opportunities for 'big data' in medicines development and regulatory science (08/11/2016)
Latest News from
Car rental companies improve treatment of consumers, thanks to EU-wide enforcement20/01/2017 16:25:00
Following a strong increase of the number of complaints on car rental issues, the European Commission and national consumer authorities engaged with the five leading car rental companies to address these issues.
Human rights: Indonesia, Central African Republic and Burundi20/01/2017 15:25:00
Parliament condemns growing intolerance towards ethnic, religious and sexual minorities in Indonesia, attacks against peacekeepers in Central African Republic and breaches of human rights in Burundi, in three resolutions voted on Thursday.
UK and Gibraltar are a single Member State for the purposes of the freedom to provide services20/01/2017 15:15:00
The Advocate General concludes that the application of EU law to Gibraltar does not create new or supplementary rights between the UK and Gibraltar that are in addition to those flowing from UK and Gibraltar constitutional law.
MEPs reject EC blacklist of states at risk of money laundering20/01/2017 14:25:00
MEPs have voted to return to the EU Commission its blacklist of countries deemed to be at risk of money laundering and terrorist financing. The list is too limited, and should be expanded, e.g. to include territories that facilitate tax crimes, they said before voting the resolution on Thursday.
Refugees: MEPs demand emergency winter aid and transfers to other EU countries20/01/2017 14:15:00
EU and national authorities should provide emergency aid to help migrants & refugees to cope with freezing temperatures & snow in several parts of Europe, MEPs urged on Wednesday. They also called on EU governments to keep their promises to transfer thousands of asylum-seekers, particularly from Greece, to other countries.